Possibilities of influencing the myocardial remodeling

Current possibilities of chronic heart failure treatment with positive impact on patient prognosis interfere with the pathophysiological processes of myocardial remodeling. RAAS-inhibitors and beta-blockers are considered to be effective pharmacological therapeutics. Available non-pharmacological methods of intervention are cardiac resynchronization therapy, valvular diseases corrections and mechanical cardiac support devices. The effect of pharmacological therapy is dose-dependent and the effect of all mentioned treatment methods is additive.